Sign In
Buy PRE
$18.64
-0.600 (-3.12%)
At Close: Jul 31, 2026
Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call
08:30am, Friday, 08'th May 2026
NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), the parent company of IM8, the premium health and longevity brand co-founded with Davi
Prenetics' IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership
08:30am, Thursday, 07'th May 2026
NEW YORK and MIAMI, May 07, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), the parent company of IM8, the premium health and longevity brand co
TSXV: ITR; NYSE American: ITRG www.integraresources.com VANCOUVER, BC, April 29, 2026 /PRNewswire/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American: ITRG) is pleased
Prenetics Global: Quarterly Subscription Focus Could Turn $120M AAR Into A Billion-Dollar Machine
07:23am, Friday, 24'th Apr 2026
I am strongly bullish on Prenetics Global Limited, driven by the IM8 product and a successful shift to quarterly subscriptions doubling customer value. PRE's revenue is projected to grow 105.7% YoY in
Prenetics Global: On Course To Hit Profitability Amid Globalization Drive
11:08am, Saturday, 18'th Apr 2026
Prenetics Global Limited (PRE) remains a buy, with a 15% near-term and 60% 24-month upside potential based on robust revenue growth projections. PRE's strategic focus on IM8, divestiture of non-core a
Comparing Prenetics Global (NASDAQ:PRE) & GH Research (NASDAQ:GHRS)
04:27am, Wednesday, 15'th Apr 2026
Prenetics Global (NASDAQ: PRE - Get Free Report) and GH Research (NASDAQ: GHRS - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two busi
Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation
11:00am, Tuesday, 24'th Mar 2026
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and
Prenetics Global CEO Touts IM8 Breakout Growth, Guides $180M-$200M Revenue at Conference
02:03am, Monday, 23'rd Mar 2026
Prenetics Global (NASDAQ: PRE) CEO and co-founder Danny Yeung told investors the company delivered what he described as a "breakout growth story" in 2025, driven by the rapid expansion of its IM8 dire
BNP PARIBAS ACCELERATES ASSET MANAGEMENT GROWTH WITH PRE-TAX INCOME SET TO DOUBLE BY 2030
02:00am, Tuesday, 17'th Mar 2026
BNP PARIBAS ACCELERATES ASSET MANAGEMENT GROWTH WITH PRE-TAX INCOME SET TO DOUBLE BY 2030 PRESS RELEASE Paris, 17 March 2026 BNP Paribas today unveiled its 2030 Strategic Plan for its scaled and integ
Prenetics Global Limited (PRE) Q4 2025 Earnings Call Transcript
12:14pm, Monday, 23'rd Feb 2026
Prenetics Global Limited (PRE) Q4 2025 Earnings Call Transcript
Top Small-Cap Stocks Leading The Market Rotation
01:24pm, Wednesday, 18'th Feb 2026
Small-cap stocks are crushing the market amid a major rotation away from mega tech as market breadth strengthens, boosted by declining interest rates, solid earnings, and a resilient economy. Every me
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
09:25am, Wednesday, 18'th Feb 2026
Final Milestone in Strategic Transformation Positions Company to Accelerate IM8 Global Expansion with Zero Debt Q4 and Full-Year 2025 Financial Results to be Announced on February 18, 2026 NEW YORK, F
Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY
09:11am, Wednesday, 18'th Feb 2026
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and l
Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors
04:30pm, Tuesday, 17'th Feb 2026
Appointment Strengthens Board with Deep Clinical and Commercial Expertise in Healthspan Optimization, Aligning with IM8 Growth Strategy NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Lim
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
08:00am, Tuesday, 17'th Feb 2026
Final Milestone in Strategic Transformation Positions Company to Accelerate IM8 Global Expansion with Zero Debt Q4 and Full-Year 2025 Financial Results to be Announced Pre-Market on February 18, 2026
